Hanzely P, Holm K, Bjørnholt JV, Melum E, Hov JR, Rasmussen H(2025) Efficacy of oral and rectal administration of human faecal microbiota transplant (FMT) in human microbiota-associated mouse models Sci Rep(in press) DOI 10.1038/s41598-025-32072-0, PubMed 41429881
Massonnaud CR, Peiffer-Smadja N, Poignard P, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lapique EL, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Vincent Le Moing, Piroth L, Sellier Pet al.(2025) Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial Clin Microbiol Infect(in press) DOI 10.1016/j.cmi.2025.12.014, PubMed 41429349
Greve-Isdahl M, Møller TKR, Bekkevold T, Baranowska-Hustad MN, Julin CH, Laake I, Berg AS, Aavitsland P, Knudsen PK, Aase A, Størdal K(2025) Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023 Euro Surveill, 30(50) DOI 10.2807/1560-7917.ES.2025.30.50.2500450, PubMed 41414933
